Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -2.45 is 64% above its 5-year average of -6.77, near the high end of its 5-year range (-14.19–-2.44).
18.33% above its 12-month average of -3.00.
Reported quarterly EPS; no daily interpolation. Q4 FY2026 (2026-06-30): -0.54.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-2.45
EARNINGS PER SHARE (EPS) AVG TTM
-3.00
EARNINGS PER SHARE (EPS) AVG 3Y
-4.04
EARNINGS PER SHARE (EPS) AVG 5Y
-6.77
EARNINGS PER SHARE (EPS) AVG 10Y
-13.20
EARNINGS PER SHARE (EPS) AVG 15Y
-18.27
EARNINGS PER SHARE (EPS) AVG 20Y
-20.97
CURRENT VS TTM AVG
+18.33%
CURRENT VS 3Y AVG
+39.39%
CURRENT VS 5Y AVG
+63.79%
CURRENT VS 10Y AVG
+81.44%
CURRENT VS 15Y AVG
+86.59%
CURRENT VS 20Y AVG
+88.32%
Pluri Inc.
Market Cap
$11.33M
Earnings Per Share (EPS)
-2.45
TTM Avg
-3.00
3Y Avg
-4.04
5Y Avg
-6.77
Market Cap
$11.38M
Earnings Per Share (EPS)
-1.34
TTM Avg
-1.18
3Y Avg
-34.71
5Y Avg
-76.23
Market Cap
$11.25M
Earnings Per Share (EPS)
-1.64
TTM Avg
-2.15
3Y Avg
-4.34
5Y Avg
-5.45
Market Cap
$11.19M
Earnings Per Share (EPS)
-1.70
TTM Avg
-1.75
3Y Avg
-3.38
5Y Avg
-5.94
Market Cap
$10.94M
Earnings Per Share (EPS)
-4.43
TTM Avg
-27.97
3Y Avg
-98701.49
5Y Avg
-256134.32
Market Cap
$11.00M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.21
3Y Avg
-0.25
5Y Avg
-0.25
Market Cap
$11.08M
Earnings Per Share (EPS)
-2.50
TTM Avg
-0.85
3Y Avg
-11.13
5Y Avg
-30.50
Market Cap
$11.01M
Earnings Per Share (EPS)
-3.20
TTM Avg
-7.58
3Y Avg
-60.73
5Y Avg
-69.78
Market Cap
$11.46M
Earnings Per Share (EPS)
-0.73
TTM Avg
-0.46
3Y Avg
-0.46
5Y Avg
-0.46
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pluri Inc. (PLUR) | $11.33M | -2.45 | -3.00 | -4.04 | -6.77 |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.38M | -1.34 | -1.18 | -34.71 | -76.23 |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.25M | -1.64 | -2.15 | -4.34 | -5.45 |
| VistaGen Therapeutics, Inc. (VTGN)vs › | $11.19M | -1.70 | -1.75 | -3.38 | -5.94 |
| Cerenome, Inc. (CNSY)vs › | $10.94M | -4.43 | -27.97 | -98701.49 | -256134.32 |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.00M | N/A | -0.21 | -0.25 | -0.25 |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.08M | -2.50 | -0.85 | -11.13 | -30.50 |
| BioVie Inc. (BIVI)vs › | $11.01M | -3.20 | -7.58 | -60.73 | -69.78 |
| Caring Brands, Inc. (CABR)vs › | $11.46M | -0.73 | -0.46 | -0.46 | -0.46 |
| Polyrizon Ltd. (PLRZ)vs › | $10.83M | N/A | -68.10 | -34.05 | -22.70 |
Trailing EPS (TTM)
$-2.45
Forward EPS (Est.)
$-1.90
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-06-30 | -2.44 |
| 2025-06-30 | -3.56 |
| 2024-06-30 | -3.99 |
| 2023-06-30 | -6.18 |
| 2022-06-30 | -10.24 |
| 2021-06-30 | -14.19 |
| 2020-06-30 | -12.80 |
| 2019-06-30 | -23.20 |
| 2018-06-30 | -19.74 |
| 2017-06-30 | -25.45 |
| 2016-06-30 | -23.38 |
| 2015-06-30 | -28.09 |
| 2014-06-30 | -33.92 |
| 2013-06-30 | -30.50 |
| 2012-06-30 | -26.88 |
| 2011-06-30 | -27.82 |
| 2010-06-30 | -35.06 |
| 2009-06-30 | -50.07 |
| 2008-06-30 | -130.77 |
| 2007-06-30 | -467.52 |
| 2006-06-30 | -639.99 |
| 2005-06-30 | -202.86 |
| 2004-06-30 | -120.34 |
| 2003-06-30 | -27.71 |
| 2002-06-30 | -4.66 |
